Suven Life Sciences reports two-fold rise in Q4 net profit

05 May 2012 Evaluate

Suven Life Sciences has reported results for fourth quarter ended March 31, 2011.

On the standalone basis, the company has posted a rise of 137.14% in its net profit at Rs 8.30 crore for the quarter ended March 31, 2012 as compared to Rs 3.50 crore for the same quarter in the previous year. Total income has increased by 36.96% at Rs 62.51 crore for quarter under review as compared to Rs 45.64 crore for the quarter ended March 31, 2011.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.

Suven Life Sciences Share Price

133.50 -3.40 (-2.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×